Emmanuelle Waubant, MD
Enriched profileProfessor of Neurology and Pediatrics, University of California, San Francisco · University of California, San Francisco
Emmanuelle Waubant is Professor of Neurology and Pediatrics, University of California, San Francisco at University of California, San Francisco. OpenAlex indexes 512 publications with 47,771 citations (h-index 81); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Neurology profiles in the findmyKOL directory.
Data verified 16 Oct 2026
Overview
Updated 16 Oct 2026
Emmanuelle Waubant, M.D., is Professor of Neurology and Pediatrics, University of California, San Francisco. The public record shows 512 publications with 47,771 citations (h-index 81), centered on Multiple Sclerosis Research Studies, Polyomavirus and related diseases, Peripheral Neuropathies and Disorders. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 3 companies, 2 NIH-funded awards (2010–2023).
- Most recent indexed publication: 2026 · Neurology(R) neuroimmunology & neuroinflammation
- Top research focus: Multiple Sclerosis Research Studies
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 3 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 38 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 250.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- A Study of Oxidative Pathways in MS Fatigue
Sponsor: University of California, San Francisco
- Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis
Sponsor: University of California, San Francisco
Industry payments
Updated 16 Oct 2026
3 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- TG Therapeutics, Inc.Program year20252 payments
- F. Hoffmann-La Roche AGProgram year20251 payment
- Roche Products LimitedProgram year20211 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
51%Potassium Channel Blocker19.4%Dalfampridine Er100%Part D≥13 patientsGabapentinoids12.5%Gabapentin58%Pregabalin42%Part D<11 patients+ 4 more classes in this area
Cancer & immunology
25.1%CD20-directed Cytolytic Antibody12.9%Kesimpta Pen100%Part D<11 patientsOther immunosuppressants12.2%Dimethyl Fumarate100%Part D<11 patientsMusculoskeletal
10.6%gamma-Aminobutyric Acid-ergic Agonist10.6%Baclofen100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 16 Oct 2026
2 NIH research awards on record, funded 2010–2023 per NIH RePORTER. The latest:
- Metabolic correlates of disease activity and disability progression in pediatric MS
University of California, San Francisco
FY2023$279,374R01NS117541 - Metabolic correlates of disease activity and disability progression in pediatric MS
University of California, San Francisco
FY2022$401,765R01NS117541 - Metabolic correlates of disease activity and disability progression in pediatric MS
University of California, San Francisco
FY2021$422,773R01NS117541
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Reduced Paramagnetic Rim Visibility Signals Lesion Aging and Tissue Degeneration in Progressive Multiple Sclerosis: Impact on Clinical Trials.
Neurology(R) neuroimmunology & neuroinflammation
Article2026 - Impaired control of autoimmunity increases pediatric multiple sclerosis risk in EBNA-1-seropositives and -seronegatives.
Proceedings of the National Academy of Sciences of the United States of America
Article2026 - Adenotonsillectomy is associated with increased risk and disease activity in pediatric-onset multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England)
Article2026
Most-cited works
by citation count (OpenAlex)- 01Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaArticle9,796 citations2011
- 02Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteriaArticle8,133 citations2017
- 03Defining the clinical course of multiple sclerosisArticle3,165 citations2014
- 04B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple SclerosisArticle2,434 citations2008
- 05
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/emmanuelle-waubant-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
profiles.ucsf.edu/emmanuelle.waubant/65
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- M.D.
University of Lille, France
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →waubantlab.ucsf.edu ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →waubantlab.ucsf.edu ↗
Editorial & leadership roles
journal and society appointments- President
Americas Committee on Treatment and Research in MS (ACTRIMS)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗ - Founder and Chair
International Women in MS
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗ - Member
U.S. Pediatric MS Steering Committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗ - Chair
International Clinical Trial Task Force for pediatric MS
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
Awards & honors
honors on the public record- Fellow
American Academy of Neurology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗ - Fellow
American Neurological Association
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
- Race to Erase MS
Medical Director
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →waubantlab.ucsf.edu ↗ - Director
Regional Pediatric MS Center at UCSF
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →waubantlab.ucsf.edu ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cslide.ctimeetingtech.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neurologylive.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aan.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Joel Palefsky, MD
University of California, San Francisco
Peter Hunt, MD
University of California, San Francisco
Owen Wolkowitz, MD
University of California, San Francisco
Emily Bergsland, MD
University of California, San Francisco
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida